Income Statement (TTM)
Biotest Aktiengesellschaft - Preferred Stock Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.
All numbers are times 1,000,000 except per share units.
|
2020 09-30 |
2020 12-31 |
2021 03-31 |
2021 06-30 |
2021 09-30 |
2021 12-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2022 12-31 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
2023 12-31 |
2024 03-31 |
2024 06-30 |
2024 09-30 |
2024 12-31 |
2025 03-31 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 466 | 484 | 506 | 507 | 514 | 516 | 512 | 511 | 505 | 516 | 517 | 538 | 656 | 685 | 783 | 781 | 707 | 726 | 635 |
| Change (%) | 3.95 | 4.61 | 0.14 | 1.34 | 0.31 | -0.80 | -0.12 | -1.15 | 2.20 | 0.25 | 4.04 | 21.79 | 4.42 | 14.31 | -0.17 | -9.51 | 2.72 | -12.53 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 329 | 354 | 382 | 387 | 394 | 435 | 428 | 429 | 425 | 391 | 394 | 398 | 368 | 404 | 436 | 432 | 459 | 502 | 488 |
| Change (%) | 7.63 | 7.85 | 1.39 | 1.83 | 10.30 | -1.68 | 0.35 | -0.86 | -8.04 | 0.72 | 1.02 | -7.44 | 9.74 | 7.94 | -1.05 | 6.37 | 9.38 | -2.89 | |
| % of Revenue | 70.63 | 73.13 | 75.40 | 76.34 | 76.71 | 84.35 | 83.60 | 83.99 | 84.24 | 75.80 | 76.15 | 73.94 | 56.19 | 59.06 | 55.76 | 55.27 | 64.96 | 69.18 | 76.81 |
| Gross Operating Profit | 137 | 130 | 125 | 120 | 120 | 81 | 84 | 82 | 80 | 125 | 123 | 140 | 287 | 280 | 346 | 350 | 248 | 224 | 147 |
| Change (%) | -4.90 | -4.23 | -3.69 | -0.25 | -32.58 | 3.97 | -2.50 | -2.69 | 56.91 | -1.20 | 13.70 | 104.70 | -2.40 | 23.51 | 0.95 | -29.13 | -9.65 | -34.18 | |
| % of Revenue | 29.37 | 26.87 | 24.60 | 23.66 | 23.29 | 15.65 | 16.40 | 16.01 | 15.76 | 24.20 | 23.85 | 26.06 | 43.81 | 40.94 | 44.24 | 44.73 | 35.04 | 30.82 | 23.19 |
| SG&A | 82 | 80 | 80 | 78 | 77 | 82 | 82 | 83 | 84 | 82 | 84 | 84 | 84 | 84 | 86 | 87 | 85 | 83 | 81 |
| Change (%) | -3.05 | 0.25 | -2.51 | -0.51 | 6.08 | -0.12 | 1.47 | 0.60 | -2.03 | 2.81 | 0.36 | -0.59 | 0.36 | 1.66 | 1.28 | -2.19 | -1.77 | -3.12 | |
| % of Revenue | 17.60 | 16.42 | 15.74 | 15.32 | 15.04 | 15.90 | 16.01 | 16.27 | 16.55 | 15.87 | 16.27 | 15.70 | 12.81 | 12.31 | 10.95 | 11.11 | 12.01 | 11.48 | 12.72 |
| R&D | 56 | 56 | 56 | 55 | 54 | 52 | 51 | 50 | 51 | 50 | 50 | 57 | 56 | 67 | 71 | 65 | 68 | 57 | 57 |
| Change (%) | -0.18 | 0.54 | -1.96 | -0.91 | -4.04 | -3.25 | -1.78 | 3.42 | -1.75 | -0.40 | 12.92 | -1.23 | 19.07 | 6.29 | -7.89 | 3.52 | -16.10 | 0.18 | |
| % of Revenue | 12.00 | 11.52 | 11.08 | 10.84 | 10.60 | 10.14 | 9.89 | 9.73 | 10.18 | 9.78 | 9.72 | 10.55 | 8.56 | 9.76 | 9.07 | 8.37 | 9.58 | 7.82 | 8.96 |
| OpEx | 472 | 492 | 520 | 524 | 525 | 566 | 558 | 562 | 564 | 536 | 542 | 530 | 500 | 568 | 604 | 606 | 637 | 639 | 623 |
| Change (%) | 4.15 | 5.69 | 0.81 | 0.17 | 7.93 | -1.48 | 0.77 | 0.21 | -4.84 | 1.01 | -2.22 | -5.68 | 13.67 | 6.36 | 0.31 | 5.13 | 0.38 | -2.53 | |
| % of Revenue | 101.37 | 101.57 | 102.63 | 103.31 | 102.12 | 109.87 | 109.11 | 110.08 | 111.60 | 103.91 | 104.70 | 98.40 | 76.21 | 82.95 | 77.18 | 77.55 | 90.10 | 88.05 | 98.11 |
| Operating Income | -6 | -8 | -13 | -17 | -11 | -51 | -47 | -52 | -59 | -20 | -24 | 9 | 156 | 117 | 179 | 175 | 70 | 87 | 12 |
| Change (%) | 18.75 | 75.00 | 26.32 | -35.12 | 366.97 | -8.45 | 10.52 | 13.79 | -65.53 | 20.30 | -135.39 | 1,713.95 | -25.19 | 53.04 | -1.79 | -60.09 | 24.00 | -86.18 | |
| % of Revenue | -1.37 | -1.57 | -2.63 | -3.31 | -2.12 | -9.87 | -9.11 | -10.08 | -11.60 | -3.91 | -4.70 | 1.60 | 23.79 | 17.05 | 22.82 | 22.45 | 9.90 | 11.95 | 1.89 |
| Interest Expense | -28 | -13 | -7 | -7 | -4 | -12 | -13 | -15 | -18 | -18 | -24 | -28 | -32 | -37 | -36 | -35 | -32 | -30 | -30 |
| Change (%) | -52.88 | -46.56 | 4.29 | -49.32 | 235.14 | 7.26 | 13.53 | 21.19 | 1.09 | 27.03 | 18.72 | 13.98 | 15.09 | -1.37 | -3.05 | -9.14 | -4.72 | -1.32 | |
| % of Revenue | -5.97 | -2.71 | -1.38 | -1.44 | -0.72 | -2.40 | -2.60 | -2.96 | -3.62 | -3.58 | -4.54 | -5.18 | -4.85 | -5.35 | -4.61 | -4.48 | -4.50 | -4.17 | -4.71 |
| Net Income | -34 | -31 | -35 | -33 | -28 | -63 | -54 | -65 | -69 | -32 | -47 | -10 | 91 | 127 | 177 | 164 | 68 | 26 | -24 |
| Change (%) | -6.55 | 10.51 | -5.19 | -15.20 | 127.24 | -14.51 | 20.11 | 6.45 | -54.26 | 48.90 | -78.60 | -1,000.00 | 39.71 | 39.29 | -7.07 | -58.33 | -61.46 | -192.80 | |
| % of Revenue | -7.21 | -6.48 | -6.85 | -6.49 | -5.43 | -12.30 | -10.60 | -12.74 | -13.72 | -6.14 | -9.12 | -1.88 | 13.87 | 18.55 | 22.60 | 21.04 | 9.69 | 3.64 | -3.86 |
Source: Capital IQ
